期刊文献+

肺癌的液体活检和检测技术进展 被引量:5

下载PDF
导出
摘要 原发性肺癌是我国常见的恶性肿瘤之一。据统计,2013年我国主要癌症发病顺位和死因顺位排第一的均是肺癌,肺癌年龄标化病死率高达40.41/10万。肺癌具有发病率高、发病机制复杂、早期难以发现、治疗效果不佳等特点。肿瘤标志物有助于早期诊断肺癌,对早发现、早治疗有重要作用,并在精准医疗和个体化治疗中起重要作用。根据《原发性肺癌诊疗规范(2015版)》,癌胚抗原、细胞角蛋白19片段抗原、
出处 《国际检验医学杂志》 CAS 2016年第17期2429-2431,共3页 International Journal of Laboratory Medicine
基金 国家自然科学基金资助项目(81171656)
  • 相关文献

参考文献24

  • 1支修益,石远凯,于金明.中国原发性肺癌诊疗规范(2015年版)[J].中华肿瘤杂志,2015,37(1):67-78. 被引量:1232
  • 2Edwards BK,Anne-Michelle MS, Mariotto AB, et al. An-nual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact onsurvival among persons with lung, colorectal, breast, orprostate cancer[J], Cancer, 2014 ,120(9) : 1290-1314.
  • 3石远凯孙燕,余金明,等.中国晚期原发性肺癌诊治专家共识(2016年版)[J].中国肺癌肿瘤杂志,2016,9(1):1-15.
  • 4〇'FlahertyJD, Gray S, Richard D,et al. Circulating tumourcells,their role in metastasis and their clinical utility in lungcancer[J]. Lung Cancer,2012,76(1) : 19-25.
  • 5Dorsey JF,Kao GD, Macarthur KM,et al. Tracking viablecirculating tumor cells(CTCs) in the peripheral blood ofnon-small cell lung cancer (NSCLC) patients undergoingdefinitive radiation therapy: pilot study results [J]. Canc-er, 2015 ,121 (1) : 139-149.
  • 6Krebs MG,Sloane R,Priest L,et al. Evaluation and prog-nostic significance of circulating tumor cells in patientswith non-small-cell lung cancer[J], J Clin 〇ncol,2011,29(12).1556-1563.
  • 7Schwarzenbach H, Hoon DS,Pantel K. Cell-free nucleicacids as biomarkers in cancer patients[J]. Nat Rev Canc-er,2011,11(6) :426-437.
  • 8Thierry AR, Mouliere F,El Messaoudi S,et al. Clinicalvalidation of the detection of KRAS and BRAF mutationsfrom circulating tumor DNA[J]. Nat Med, 2014,20 (4):430-435.
  • 9Qiu M,Wang J,Xu Y,et al. Circulating tumor DNA is ef-fective for the detection of EGFR mutation in non-smallcell lung cancer : a meta-analysis[J]. Cancer Epidemiol Bi-omarkers Prev,2015,24(1) :206-212.
  • 10Nie K, Jia Y, Zhang X, et al. Cell-free circulating tumorDNA in plasma/serum of non-small cellluncancer [J].Tumour Biol,2015,36(1):7-19.

二级参考文献33

  • 1Siegel R,Ward E,Brawley 0,et al.Cancer statistics,2011:theimpact of eliminating socioeconomic and racial disparities on pre-mature cancer deaths[J].CA Cancer J Clin,2011,61(4):212-236.
  • 2Biedler JL'Riehm H.Cellular resistance to actinomycin D in Chi-nese hamster cells in vitro:cross-resistance,radioautographic *and cytogenetic studies[J],Cancer Res,1970,30(4):1174-1184.
  • 3Roberti A,La Sala D,Cinti C.Multiple genetic and epigenetic in-teracting mechanisms contribute to clonally selection of drug-re-sistant tumors:current views and new therapeutic prospective[J].J Cell Physiol,2006,207(3):571-581.
  • 4Calin G A,Sevignani C,Dumitru C D,et al.Human microRNAgenes are frequently located at fragile sites and genomic regionsinvolved in cancers[J].Proc Natl Acad Sci U S A,2004,101(9):2999-3004.
  • 5Mcnally L,Manne U* Grizzle W.Post-transcriptional processing of ge-netic information and its relation to cancer[J].Biotech Histochem,2013,88(7):365-372.
  • 6Zhao Y,Srivastava D.A developmental view of microRNA func-tion[J],Trends Biochem Sci,2007,32(4):189-197.
  • 7Okouoyo S,Herzer K,Ucur E,et al.Rescue of death receptor andmitochondrial apoptosis signaling in resistant human NSCLC invivo[J].Int J Cancer,2004,108(4):580-587.
  • 8Ceppi P,Mudduluru G,Kumarswamy R,et al.Loss of miR-200cexpression induces an aggressive? invasive,and chemoresistantphenotype in non-small cell lung cancer[J].Mol Cancer Res,2010,8(9):1207-1216.
  • 9Slot AJ,Wise DD,Deeley RG,et al.Modulation of human multi-drug resistance protein(MRP)1(ABCC1)and MRP2(ABCC2)transport activities by endogenous and exogenous glutathione-conjugated catechol metabolites[J].Drug Metab Dispos,2008,36(3):552-560.
  • 10Cole SP'Deeley RG.Multidrug resistance mediated by the ATP-binding cassette transporter protein MRP[J].Bioessays,1998,20?11):931-940.

共引文献1251

同被引文献48

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部